Abstract
Henoch-Schönlein purpura (HSP) frequently occurs in children below the age of 15 years and is rare with increasing age. Prognosis and therapy largely depend on the clinical presentation. The disease may be preceded by an upper respiratory tract infection, and drugs have also been implicated in the pathogenesis of the disease. Most children recover from the illness, whereas 40% of adults have persistent hematuria and 10% develop chronic renal failure. Recent studies strongly suggest that adults with HSP should be monitored for prolonged periods and treated aggressively. Here, we present a case of a patient with HSP who developed multiorgan failure requiring assistance in breathing and dialysis, and also sustained gastrointestinal bleeding despite aggressive immunosuppressive therapy. In analogy to published data in children with severe HSP, the patient was treated by plasma exchange in combination with low dose oral cyclophosphamide, while high dose steroids were reduced over time. The patient could be discharged 70 days after admission. One year after discharge, the patient is doing well without any signs of activity of HSP and completely unremarkable renal function. The maintenance daily dose of steroids is 7.5 mg.
References
Heberden W (1802) Commentaries on the history and cure of diseases. T. Payne, London, p 395
Schönlein JL (1847) Allgemeine und Spezielle Pathologie und Therapie, 3rd edn, vol 1. p 48
Mills JA, Michael BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein Purpura. Arthritis Rheum 33:1114–1121
Molliaca F, LiVolti S, Garozzo R, Russo G (1992) Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 151:140–144
Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioko T, Khono M (1999) Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. Am J Kidney Dis 33:427–433
Kawassaki Y, Suzuki J, Muraai M, Takahashi A, Isome M, Nozawa R, Suzuki S, Suzuki H (2004) Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis. Pediatr Nephrol 19:920–923
Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch-Schönlein Purpura (ISRCTN85109383). BMC Med 2:7
Ilan Y, Naparstek Y (2002) Henoch-Schönlein purpura in children and adults: is it on entity? Semin Arthritis Rheum 32(3):139–140 (December)
Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 12:238–243
Gianviti A, Trompeter RS, Barratt TM, Lythgoe MF, Dillon MJ (1996) Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 75:186–190
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rech, J., Fuchs, F., Kallert, S. et al. Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement. Clin Rheumatol 26, 112–114 (2007). https://doi.org/10.1007/s10067-005-0113-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0113-1